Clinical Study of Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of Relapsed/Refractory Non-Hodgkin Lymphoma
Clinical trial NCT05420493 · UNKNOWN
Trial details
- NCT number
- NCT05420493
- Sponsor
- Chongqing Precision Biotech Co., Ltd
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-06
- Primary completion
- 2024-09-30
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.